API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://endpts.com/biosplice-searches-for-a-path-forward-after-osteoarthritis-drug-fails-late-stage-study/
https://www.globenewswire.com/news-release/2024/04/18/2865193/0/en/Biosplice-Announces-Upcoming-Presentation-of-Successful-OA-07-Phase-3-Long-Term-Structure-and-Pain-Function-Results-for-Lorecivivint-for-Treatment-of-Knee-Osteoarthritis-at-OARSI-C.html
https://www.globenewswire.com//news-release/2023/11/13/2778824/0/en/Biosplice-Presents-Successful-Structure-and-Pain-Results-from-Completed-Phase-3-Long-Term-Extension-Clinical-Trial-for-Lorecivivint-for-the-Treatment-of-Knee-Osteoarthritis.html
https://www.prnewswire.com/news-releases/samumed-and-united-therapeutics-announce-north-american-license-agreement-for-samumeds-ipf-drug-candidate-300713382.html